Avadel Pharmaceuticals (AVDL) Total Current Liabilities: 2009-2021
Historic Total Current Liabilities for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $21.0 million.
- Avadel Pharmaceuticals' Total Current Liabilities rose 136.03% to $41.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $41.5 million, marking a year-over-year increase of 136.03%. This contributed to the annual value of $21.0 million for FY2021, which is 38.99% up from last year.
- Per Avadel Pharmaceuticals' latest filing, its Total Current Liabilities stood at $21.0 million for FY2021, which was up 38.99% from $15.1 million recorded in FY2020.
- Avadel Pharmaceuticals' Total Current Liabilities' 5-year high stood at $86.5 million during FY2017, with a 5-year trough of $15.1 million in FY2020.
- Moreover, its 3-year median value for Total Current Liabilities was $21.0 million (2021), whereas its average is $24.0 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Total Current Liabilities plummeted by 58.01% in 2020, and later surged by 38.99% in 2021.
- Over the past 5 years, Avadel Pharmaceuticals' Total Current Liabilities (Yearly) stood at $86.5 million in 2017, then tumbled by 55.65% to $38.4 million in 2018, then dropped by 6.25% to $36.0 million in 2019, then slumped by 58.01% to $15.1 million in 2020, then skyrocketed by 38.99% to $21.0 million in 2021.